Please find below a selection of websites that you may find useful to support the use of anticoagulation for your patients.
Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance at www.hpra.ie
Adverse reactions should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or email@example.com